INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
AA
Corporate insider

Alexander Margaret A.

Director, President and CEOCIK 0002036798

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score31
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Open-market sale
SELL$17K
11.7K sh
Feb 23, 2026Mar 2, 2026
traded Feb 23, 2026
+7dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Ovid Therapeutics Inc.Director, President and CEO · Jan 5, 2026
5
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Grant or award
A
—
1.44M sh
Feb 26, 2026
Mar 2, 2026
traded Feb 26, 2026
+4d
SEC FORM 4

Evidence

9
AA
Alexander Margaret A.Director, President and CEO
OVIDOvid Therapeutics Inc.
Grant or award
A—
890.0K sh
Jan 4, 2026Jan 5, 2026
traded Jan 4, 2026
+1dSEC FORM 4

Evidence